Tuesday, September 30, 2014 11:06:26 PM
We provide expert and experienced urological diagnosis and treatment personalised on the individual man or woman with the newest and best technology available.
We have developed a large volume of experience by focusing individually on the diagnosis and treatment of specific bladder, prostate, kidney, penile ( http://www.dailymail.co.uk/health/article-1160745/ME-AND-MY-OPERATION-I-thought-sex-life-Then-I-remarkable-op.html ) and other urological problems. Our patients come from all over the UK including Central London and as far as Scotland and Cyprus.
We specialise in robotic surgery for prostate and kidney problems. Omer Karim was named as one of the top prostate cancer surgeons by the Daily Mail ( http://www.dailymail.co.uk/health/article-1325743/Who-best-surgeons-treating-prostate-cancer.html ) . Read reports by patients ( http://www.londonroboticscentre.com/Conditions-Patient-Stories.aspx ) on whom Omer Karim has operated. Both Omer Karim ( http://www.windsorurology.co.uk/About_us/Mr_Omer_Karim.aspx ) and Marc Laniado ( http://www.windsorurology.co.uk/About_us/Mr_Marc_Laniado.aspx ) specialise in nerve-sparing robotic prostatectomy for prostate cancer with audited outcomes demonstrating high quality results.
• 4Kscore Test ( http://www.windsorurology.co.uk/Downloads/4KscoreClinicalBrochureFinal.pdf ) a blood test better than PSA to more accurately identify men at high-risk for prostate cancer likely to cause problems
•We have adopted the newest techniques including: MRI/TRUS fusion for MRI-targeted prostate biopsies
•prostate-mapping
• Prolaris test ( http://www.windsorurology.co.uk/Downloads/PROLARISBROCHUREforprostatecancerprognosis20130803.pdf ) to avoid overtreatment in high risk disease and suggest treatment in apparently low-risk disease
•HIFU for focal therapy i.e. treat the important cancer but leave the rest of the prostate and nerves for erections unaffected
•3rd generation da Vinci Si Surgical system from Intuitive Surgical to offer nerve-sparing robotic prostatectomy ( http://www.windsorurology.co.uk/Treatments/roboticprostatectomy.aspx ) as a treatment for prostate cancer. The da Vinci Si Surgical sytem harnesses the best of robotic accuracy, human judgement and minimal invasiveness to remove prostate cancer, and maximally preserve potency and continence. PCaSo recently had an article ( http://www.windsorurology.co.uk/Downloads/PCaSoFeb2009articleonroboticprostatectomy.pdf ) on our robot.
We recently hosted the 2nd UK course on robotic prostate and kidney cancer surgery ( http://www.roboticsurgery.org.uk/ ) on Feb 2 and 3rd attended by urologists from all over the world.
Please read our links on clinical information or use the search box for more information.
Click here to go to an online calculator on the risk of prostate cancer ( http://www.compass.fhcrc.org/edrnnci/bin/calculator/main.asp?t=prostate&sub=disclaimer&v=prostate&m=&x=Prostate%20Cancer )
Booking an appointment
The consultants are available every weekday (8am to 8pm) and on Saturday mornings, so you can have your first appointment within 24 hours. In emergencies, we see patients out of hours including Sundays.
Either call 01753 847 247 or, to make an appointment for a specific consultant, call:
Mr Omer Karim MS FRCS(Urol)
Tel: 01753 621 815
Fax: 01753 869 094
Mr Marc Laniado MD FEBU FRCS(Urol)
Tel: 01753 860 071
Fax: 01753 869 094
Mr Hanif Motiwala MS FRCS(Urol)
Tel: 01753 858 467
Fax: 01753 623 505
You can also complete an online form ( http://www.windsorurology.co.uk/Referrals/Appointment_Request_Form.aspx ) here to request an appointment.
The secretaries are available Monday to Friday usually between 8.30 am and 6pm. At other times, either leave a phone message or in an emergency contact the switchboard at the Princess Margaret Hospital (01753 743 434) and they will be able to reach us.
Recent OPK News
- OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 09:02:37 PM
- AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • GlobeNewswire Inc. • 03/05/2024 01:52:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 09:05:23 PM
- NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st • PR Newswire (US) • 02/28/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:54 PM
- OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/16/2024 09:53:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:07:24 PM
- NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China • PR Newswire (US) • 02/05/2024 01:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 08:30:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:56:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:09:07 PM
- OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes • GlobeNewswire Inc. • 01/09/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:10:34 PM
- OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:26:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 06:39:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM